Bjorn Paulsson
Kista, AB, Sweden
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Labor market affiliation of patients with myeloproliferative neoplasms: a population-based matched cohort study.
Journal: Acta oncologica (Stockholm, Sweden)
Published: September 01, 2023
Healthcare resource utilization in patients with myeloproliferative neoplasms: A Danish nationwide matched cohort study.
Journal: European journal of haematology
Published: April 26, 2022
Socioeconomic cost of AML in Sweden-A population-based study using multiple nation-wide registers.
Journal: EJHaem
Published: March 09, 2021
Prospective Study of Chromogranin A as a Predictor of Progression in Patients with Pancreatic, Small-Intestinal, and Unknown Primary Neuroendocrine Tumors.
Journal: Neuroendocrinology
Published: February 27, 2019
Prediction and modeling of effects on the QTc interval for clinical safety margin assessment, based on single-ascending-dose study data with AZD3839.
Journal: The Journal of pharmacology and experimental therapeutics
Published: June 12, 2014
Population pharmacokinetic and pharmacodynamic analysis of plasma Aβ40 and Aβ42 following single oral doses of the BACE1 inhibitor AZD3839 to healthy volunteers.
Journal: Clinical pharmacology in drug development
Published: August 15, 2013
Population pharmacokinetics and safety of AZD1446, a neuronal nicotinic receptor agonist, administered in healthy volunteers.
Journal: Clinical pharmacology in drug development
Published: December 14, 2012
A randomized, double-blind, placebo-controlled crossover study of α4β 2* nicotinic acetylcholine receptor agonist AZD1446 (TC-6683) in adults with attention-deficit/hyperactivity disorder.
Journal: Psychopharmacology
Published: November 20, 2012
Showing 1-8 of 8
Last Updated: 09/26/2026